Extrafine single-inhaler triple therapy with BDP/FF/GB is effective for improving health-related quality of life and lung function in COPD.

A 2026 study published in BMC Medicine, “Integration of gut microbiome and lipid metabolism reveals the anti-cancer effects ...

Introduction Genomic testing allows for the identification of disease-causing genetic variants and may also reveal secondary ...

A phase I trial of diphencyprone for cutaneous neurofibromas in adult patients with neurofibromatosis type 1. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does ...

Neurofilament light (NfL) demonstrated superior prognostic accuracy with an area under the receiver operating characteristic ...

Higher serum vitamin D in midlife is associated with reduced tau burden in the brain, highlighting its potential role in ...

Imperative Care, Inc. announced the enrollment of the first patient in the prospective observational CLEAR-IT clinical study ...

Identifying key prognostic indicators in Wilms tumor using machine learning techniques. The effect of GLP-1 receptor agonists on outcomes in metastatic renal cell carcinoma patients undergoing immune ...

Nanoscope Therapeutics, Inc., a biotechnology company committed to developing and commercializing novel, disease-agnostic therapies for patients with photoreceptor loss and vision impairment due to ...

Please provide your email address to receive an email when new articles are posted on . The Lupus Landmark Study will enroll and follow 3,500 patients over 5 years. The study is part of the Lupus ...